JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Setting

Order Through VWR & Receive a FREE Sample

Support: [email protected]

Track Your Order

Home
Search results for: 'cb 65'

Search results for: 'cb 65'

A3285 CB 300919

Summary: Potential therapy for ovarian cancer

Soluble in DMSO
B6032 CB-5083
10 Citation

Target: p97

Summary: p97 inhibitor

insoluble in H2O; ≥20.65 mg/mL
A4240 Abiraterone
1 Citation

Summary: Potent CYP17 inhibitor

insoluble in EtOH; insoluble in H2O; ≥5.57 mg/mL
C5311 NESS 0327

Summary: extremely potent cannabinoid (CB) receptor antagonist

≤0.25 mg/mL
BA5211 Virodhamine

Summary: Virodhamine is an endogenous cannabinoid that regulates neurotransmission by activating cannabinoid (CB) receptors.
B1637 OSI-027

Summary: MTORC1/ mTORC2 inhibitor

insoluble in EtOH; insoluble in H2O; ≥32.5 mg/mL
A4127 GSK1070916

Target: Aurora Kinases

Summary: Aurora B/C inhibitor

≥25.4 mg/mL
A4390 Pemetrexed
1 Citation

Target: Thymidylate Synthase|DHFR|GARFT

Summary: TS, DHFR,GARFT and AICARFT inhibitor

insoluble in EtOH; ≥15.68 mg/mL
A1987 Ki16425
6 Citation

Target: LPA Receptors

Summary: LPA receptor antagonist

≥23.75 mg/mL
K3105 Bst DNA Polymerase

Summary: Bst DNA polymerase, an ideal choice for isothermal nucleic acid amplification.